Help us improve guidance content on our website. Complete our short survey.
Supply a non-prescription medicine
Information on how to supply a non-prescription medicine.
Resources
- Credit card payment authorisationHow to make credit card payments to the TGA.
- Export of medicines from AustraliaThis guidance is to assist with exporting medicines either for commercial supply, or for non-commercial purposes.
- Notifications process: requests to vary registered medicines where quality, safety and efficacy are not affectedOutlines types of variations that have been determined to pose a very low risk.
Latest alerts
- Multani Kaminividravana Rasa (Kamini) tabletsThe TGA has recently tested the contents of Kamini, and found ingredients in Kamini that pose a serious risk if ingested.
- Antibiotics shortage update and new guidance for health professionalsWe have updated the information about these shortages with new details about affected products and a link to an additional resource for health professionals.
- EVE Allylisopropylacetylurea tabletsThe TGA is warning consumers against taking EVE branded products that contain allylisopropylacetylurea (apronal) as they pose a significant health risk and are prohibited from sale, supply or use in Australia.
Latest articles
- Product Information safety updates - April and May 2023Medicines Safety Update - Information for health professionals
Do you read the label every time?Check the labels of all medicines and medical devices, including those you buy without a doctor’s prescription.- 2023 Seasonal Influenza VaccinesInfluenza vaccines can change from year to year as new strains of influenza virus appear. This is one reason vaccination against influenza is given every year.
Events and webinars
Latest publications
- ACM meeting statement, Out of Session Meeting, 10 November 2022Advisory Committee on Medicines meeting statement
- ACM meeting statement, Meeting 38, 30-31 March 2023Advisory Committee on Medicines meeting statement
- ACM meeting statement, Meeting 37, 3 February 2023Advisory Committee on Medicines meeting statement
Latest consultations
- Consultation: Clarification and updates to the regulation of sunscreensThe TGA is seeking feedback on proposed clarification and updates to the regulation of sunscreens. Closing date: 31 May 2023
- Public consultation on interim decisions to amend the Poisons Standard - ACMS #40 NOVEMBER 2022 (paracetamol)This consultation is for the interim decision in relation to paracetamol which was discussed at the November 2022 meeting of the Advisory Committee on Medicines Scheduling (ACMS).
- Consultation: International harmonisation of ingredient names (IHIN) – Dual labelling transition to sole medicine ingredient namesThe TGA is seeking views on ingredient names that must be displayed as both the old and new ingredient name on medicine labels.